(筆頭著者)
栗並医院のデータを使った研究以外にも、これまで糖尿病や肥満症等について多くの臨床研究および学術発表を行ってきました。以下に、筆頭著者として発表した主な論文・総説を掲載しています。
【その他の筆頭業績】
Body Muscle-to-Fat Ratio (BMFR) as a Promising Anthropometric Index for Use in the Evaluation of Insulin Resistance and Metabolic Disease Risk: a Narrative Review.
Current obesity reports 14(1) 76-76 2025年10月29日
Early Dose Escalation of Tirzepatide after Switching from Semaglutide in Type 2 Diabetes Mellitus.
Endocrinology and metabolism (Seoul, Korea) 2025年10月15日
Clinical Factors Associated with Body-weight Reduction Induced by Semaglutide 1.0 mg Weekly in Patients with Type 2 Diabetes Mellitus.
JMA journal 8(2) 526-532 2025年4月28日
Calculated estimation of the metabolic clearance rate of insulin measured by glucose clamp examination in out-patient clinical practice.
Diabetology international 15(4) 867-869 2024年10月
Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus.
Journal of clinical medicine research 13(7) 387-391 2021年7月
Characteristics of nephropathy in severely obese Japanese patients complicated with type 2 diabetes mellitus: a cross-sectional cohort study.
Endocrine 70(3) 509-516 2020年12月
Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus.
Diabetes research and clinical practice 143 134-139 2018年9月
Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus.
Diabetes research and clinical practice 142 254-263 2018年8月
Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus.
Diabetes research and clinical practice 139 122-130 2018年5月
Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus.
Clinical drug investigation 38(1) 19-27 2018年1月
Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus.
Diabetes research and clinical practice 120 65-72 2016年10月